Showing results (121-130 of 164) with videos related to

Sort By:
Pageof 17
Journal of Thrombosis and Haemostasis : JTH|June 24, 2020
Standardizing care to manage bleeding disorders in adolescents with heavy menses-A joint project from the ISTH pediatric/neonatal and women's health SSCsAyesha Zia, Peter Kouides, Dmitry Khodyakov, et al.
Leukemia & Lymphoma|September 19, 2022
Risk of second primary malignancy in patients with primary myelofibrosis: a SEER database studyUtsav Joshi, Adheesh Bhattarai, Suman Gaire, et al.
The International Journal of Artificial Organs|March 23, 2018
Prospective analysis of bleeding events in left ventricular assist device patientsSaadia Sherazi, Peter Kouides, Charles Francis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcomeA P Rapoport, J M Rowe, P A Kouides, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 3, 2010
The spectrum of haemostatic characteristics of women with unexplained menorrhagiaC H Miller, C S Philipp, S F Stein, et al.
The Journal of Infectious Diseases|August 1, 1995
Respiratory syncytial virus and influenza A infections in the hospitalized elderlyA R Falsey, C K Cunningham, W H Barker, et al.
American Journal of Preventive Medicine|July 1, 1993
A performance-based incentive program for influenza immunization in the elderlyR W Kouides, B Lewis, N M Bennett, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 5, 2016
Von Willebrand factor for menorrhagia: a survey and literature reviewM V Ragni, N Machin, L M Malec, et al.
Blood|August 5, 2015
Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand diseaseJoan C Gill, Giancarlo Castaman, Jerzy Windyga, et al.
Journal of Thrombosis and Haemostasis : JTH|September 3, 2011
The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experienceM Kurth, J Puetz, P Kouides, et al.
Pageof 17